{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:41:21Z","timestamp":1791945681063,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T00:00:00Z","timestamp":1730592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejphar.2024.177096","type":"journal-article","created":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T06:27:09Z","timestamp":1730615229000},"page":"177096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Transforming growth factor-\u03b21 mediates the beneficial effects of arketamine on demyelination and remyelination in the brains of cuprizone-treated mice"],"prefix":"10.1016","volume":"985","author":[{"given":"Ming-ming","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-ting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiayun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumi","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8892-0439","authenticated-orcid":false,"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.177096_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104922","article-title":"Association between Diffusion Tensor Imaging, inflammation and immunological alterations in unipolar and bipolar depression: a review","volume":"143","author":"Aronica","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2024.177096_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/srep34594","article-title":"B cell-derived transforming growth factor-\u03b21 expression limits the induction phase of autoimmune neuroinflammation","volume":"6","author":"Bjarnad\u00f3ttir","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2024.177096_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.euroneuro.2024.05.013","article-title":"Ketamine and new targets for treatment-resistant depression: a role for transforming growth factor-\u03b21?","volume":"86","author":"Caraci","year":"2024","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.ejphar.2024.177096_bib4","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.phrs.2018.02.007","article-title":"Neurobiological links between depression and AD: the role of TGF-\u03b21 signaling as a new pharmacological target","volume":"130","author":"Caraci","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2024.177096_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106573","article-title":"Role of oxidative phosphorylation in the antidepressant effects of arketamine via the vagus nerve-dependent spleen-brain axis","volume":"199","author":"Chang","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2024.177096_bib6","article-title":"Protection of TGF-\u03b21 against neuroinflammation and neurodegeneration in A\u03b21-42-induced Alzheimer's disease model rats","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2024.177096_bib7","article-title":"A systematic review of abnormalities in intracortical myelin across psychiatric illnesses","volume":"15","author":"Chen","year":"2024","journal-title":"J. Affect. Disord. Rep"},{"issue":"2","key":"10.1016\/j.ejphar.2024.177096_bib8","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0014-4886(03)00308-X","article-title":"Transforming growth factor beta 1 may regulate the stability of mature myelin sheaths","volume":"184","author":"Day","year":"2003","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177096_bib9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","article-title":"TGF-\u03b2 signaling in health, disease, and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"7","key":"10.1016\/j.ejphar.2024.177096_bib10","doi-asserted-by":"crossref","first-page":"6121","DOI":"10.1007\/s11033-023-08419-z","article-title":"Transforming growth factor \u03b2 (TGF-\u03b2) pathway in the immunopathogenesis of multiple sclerosis (MS); molecular approaches","volume":"50","author":"Esmaeilzadeh","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177096_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiple sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"11","key":"10.1016\/j.ejphar.2024.177096_bib12","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00011-019-01275-3","article-title":"The rs3761548 FOXP3 variant is associated with multiple sclerosis and transforming growth factor \u03b21 levels in female patients","volume":"68","author":"Flauzino","year":"2019","journal-title":"Inflamm. Res."},{"issue":"12","key":"10.1016\/j.ejphar.2024.177096_bib13","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nrn.2017.136","article-title":"Regenerating CNS myelin - from mechanisms to experimental medicines","volume":"18","author":"Franklin","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177096_bib14","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1007\/s11682-020-00345-z","article-title":"White matter correlates of slowed information processing speed in unimpaired multiple sclerosis patients with young age onset","volume":"15","author":"Govindarajan","year":"2021","journal-title":"Brain Imaging Behav"},{"issue":"7","key":"10.1016\/j.ejphar.2024.177096_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022623","article-title":"Spatial and temporal profiles of growth factor expression during CNS demyelination reveal the dynamics of repair priming","volume":"6","author":"Gudi","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ejphar.2024.177096_bib16","doi-asserted-by":"crossref","first-page":"510","DOI":"10.4103\/1673-5374.293147","article-title":"Glial-derived transforming growth factor \u03b21 (TGF-\u03b21): a key factor in multiple sclerosis neuroinflammation","volume":"16","author":"Guevara","year":"2021","journal-title":"Neural Regen. Res."},{"issue":"8","key":"10.1016\/j.ejphar.2024.177096_bib17","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3390\/antiox13080914","article-title":"Evidence for TGF-\u03b21\/Nrf2 signaling crosstalk in a cuprizone model of multiple sclerosis","volume":"13","author":"Guevara","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejphar.2024.177096_bib18","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.41869","article-title":"Circulating transforming growth factor-\u03b21 facilitates remyelination in the adult central nervous system","volume":"8","author":"Hamaguchi","year":"2019","journal-title":"Elife"},{"issue":"10","key":"10.1016\/j.ejphar.2024.177096_bib19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/pcn.12902","article-title":"Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective","volume":"73","author":"Hashimoto","year":"2019","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.ejphar.2024.177096_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113935","article-title":"Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine","volume":"177","author":"Hashimoto","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.ejphar.2024.177096_bib21","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s00406-023-01570-5","article-title":"Arketamine for cognitive impairment in psychiatric disorders","volume":"273","author":"Hashimoto","year":"2023","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.ejphar.2024.177096_bib22","article-title":"Are \"mystical experiences\" essential for antidepressant actions of ketamine and the classic psychedelics?","volume":"27","author":"Hashimoto","year":"2024","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177096_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jatmed.2024.07.001","article-title":"Ketamine and its two enantiomers in anesthesiology and psychiatry: a historical review and future directions","volume":"3","author":"Hashimoto","year":"2024","journal-title":"J. Anest. Transl. Med."},{"key":"10.1016\/j.ejphar.2024.177096_bib24","article-title":"Myelin-associated oligodendrocytic basic protein-dependent myelin repair confers the long-lasting antidepressant effect of ketamine","author":"Huang","year":"2023","journal-title":"Mol. Psychiatr."},{"issue":"7","key":"10.1016\/j.ejphar.2024.177096_bib25","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1007\/s00415-023-11634-0","article-title":"Neuromyelitis optica study group (NEMOS)","volume":"270","author":"Jarius","year":"2023","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177096_bib26","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.3390\/ijms25031445","article-title":"How to use the cuprizone model to study de- and remyelination","volume":"25","author":"Kipp","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177096_bib27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.brainresbull.2007.06.021","article-title":"Intranasally delivered TGF-\u03b21 enters brain and regulates gene expressions of its receptors in rats","volume":"74","author":"Ma","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2024.177096_bib28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1471-2202-9-117","article-title":"Intranasal delivery of transforming growth factor-beta1 in mice after stroke reduces infarct volume and increases neurogenesis in the subventricular zone","volume":"9","author":"Ma","year":"2008","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.ejphar.2024.177096_bib29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-1-60761-869-0_21","article-title":"Transforming growth factor-beta: recent advances on its role in immune tolerance","volume":"677","author":"Mantel","year":"2011","journal-title":"Methods Mol. Biol."},{"issue":"19","key":"10.1016\/j.ejphar.2024.177096_bib30","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","article-title":"TGF-\u03b2 signaling in health and disease","volume":"186","author":"Massagu\u00e9","year":"2023","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177096_bib31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1750-3639.2001.tb00385.x","article-title":"The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system","volume":"11","author":"Matsushima","year":"2001","journal-title":"Brain Pathol."},{"issue":"5","key":"10.1016\/j.ejphar.2024.177096_bib32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/jnnp-2022-329806","article-title":"Psychiatric symptoms in multiple sclerosis: a biological perspective on synaptic and network dysfunction","volume":"94","author":"Menculini","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6\u20137","key":"10.1016\/j.ejphar.2024.177096_bib33","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.neuropharm.2009.02.007","article-title":"TGF-beta as a promising option in the treatment of multiple sclerosis","volume":"56","author":"Mirshafiey","year":"2009","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.ejphar.2024.177096_bib34","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/jamapsychiatry.2014.189","article-title":"Myelination and oligodendrocyte functions in psychiatric diseases","volume":"71","author":"Nave","year":"2014","journal-title":"JAMA Psychiatr."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177096_bib35","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1046\/j.1365-2249.1998.00604.x","article-title":"Blood levels of transforming growth factor-beta 1 (TGF-beta1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta1b)","volume":"113","author":"Nicoletti","year":"1998","journal-title":"Clin. Exp. Immunol."},{"issue":"12","key":"10.1016\/j.ejphar.2024.177096_bib36","doi-asserted-by":"crossref","first-page":"6804","DOI":"10.3390\/ijms25126804","article-title":"(R)-(-)-ketamine: the promise of a novel treatment for psychiatric and neurological disorders","volume":"25","author":"Shafique","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.ejphar.2024.177096_bib37","article-title":"Neuropsychiatry in demyelination disease: using depression as a prodrome for early diagnosis and treatment of multiple sclerosis","volume":"9","author":"Shail","year":"2017","journal-title":"Cureus"},{"issue":"23","key":"10.1016\/j.ejphar.2024.177096_bib38","doi-asserted-by":"crossref","first-page":"e2042","DOI":"10.1212\/WNL.0000000000005644","article-title":"White matter integrity and processing speed in sickle cell anemia","volume":"90","author":"Stotesbury","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2024.177096_bib39","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0404.2008.01036.x","article-title":"The cuprizone model of demyelination","volume":"188","author":"Torkildsen","year":"2008","journal-title":"Acta Neurol. Scand. Suppl."},{"issue":"2","key":"10.1016\/j.ejphar.2024.177096_bib40","doi-asserted-by":"crossref","first-page":"264","DOI":"10.5498\/wjp.v12.i2.264","article-title":"Insights into myelin dysfunction in schizophrenia and bipolar disorder","volume":"12","author":"Vald\u00e9s-Tovar","year":"2022","journal-title":"World J. Psychiatr."},{"key":"10.1016\/j.ejphar.2024.177096_bib41","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.brainresbull.2021.10.013","article-title":"(R)-ketamine ameliorates the progression of experimental autoimmune encephalomyelitis in mice","volume":"177","author":"Wang","year":"2021","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2024.177096_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105635","article-title":"(R)-ketamine ameliorates demyelination and facilitates remyelination in cuprizone-treated mice: a role of gut-microbiota-brain axis","volume":"165","author":"Wang","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2024.177096_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104762","article-title":"(R)-ketamine as prophylactic and therapeutic drug for neurological disorders: beyond depression","volume":"139","author":"Wang","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2024.177096_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105951","article-title":"Key role of the gut-microbiota-brain axis via the subdiaphragmatic vagus nerve in demyelination of the cuprizone-treated mouse brain","volume":"176","author":"Wang","year":"2023","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.ejphar.2024.177096_bib45","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000494976","article-title":"Cytokines and tissue damage biomarkers in first-onset neuromyelitis optica spectrum disorders: significance of interleukin-6","volume":"25","author":"Wei","year":"2018","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.ejphar.2024.177096_bib46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.euroneuro.2021.04.010","article-title":"Intranasal administration of transforming growth factor-\u03b21 elicits rapid-acting antidepressant-like effects in a chronic social defeat stress model: a role of TrkB signaling","volume":"50","author":"Wei","year":"2021","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177096_bib47","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41380-021-01121-1","article-title":"Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor","volume":"27","author":"Wei","year":"2022","journal-title":"Mol. Psychiatr."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177096_bib48","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12974-022-02557-0","article-title":"Transforming growth factor-\u03b21 protects against LPC-induced cognitive deficit by attenuating pyroptosis of microglia via NF-\u03baB\/ERK1\/2 pathways","volume":"19","author":"Xie","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.ejphar.2024.177096_bib49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/jnc.16037","article-title":"Transforming growth factor-\u03b21 protects against white matter injury and reactive astrogliosis via the p38 MAPK pathway in rodent demyelinating model","volume":"168","author":"Xie","year":"2024","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2024.177096_bib50","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jad.2024.08.222","article-title":"Effects of arketamine on depression-like behaviors and demyelination in mice exposed to chronic restrain stress: a role of transforming growth factor-\u03b21","volume":"367","author":"Xu","year":"2024","journal-title":"J. Affect. Disord."},{"issue":"9","key":"10.1016\/j.ejphar.2024.177096_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.ejphar.2024.177096_bib52","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41398-019-0624-1","article-title":"Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites","volume":"9","author":"Yang","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ejphar.2024.177096_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176075","article-title":"The role and mechanism of TGF-\u03b21 in the antidepressant-like effects of tetrahydrocurcumin","volume":"959","author":"Yang","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2024.177096_bib54","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/s41380-021-01377-7","article-title":"Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine","volume":"27","author":"Yao","year":"2022","journal-title":"Mol. Psychiatr."},{"issue":"4","key":"10.1016\/j.ejphar.2024.177096_bib55","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/cells9040843","article-title":"The cuprizone model: dos and do nots","volume":"9","author":"Zhan","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2024.177096_bib56","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pbb.2013.11.033","article-title":"R(-)-ketamine shows greater potency and longer lasting antidepressant effects than S(+)-ketamine","volume":"116","author":"Zhang","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.ejphar.2024.177096_bib57","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41398-020-0733-x","article-title":"Essential role of microglial transforming growth factor-\u03b21 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-\u03b21","volume":"10","author":"Zhang","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ejphar.2024.177096_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109219","article-title":"Arketamine, a new rapid-acting antidepressant: a historical review and future directions","volume":"218","author":"Zhang","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2024.177096_bib59","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41380-020-00930-0","article-title":"Oligodendrocyte lineage cells and depression","volume":"26","author":"Zhou","year":"2021","journal-title":"Mol. Psychiatr."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924007866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924007866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T01:29:04Z","timestamp":1733621344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924007866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":59,"alternative-id":["S0014299924007866"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177096","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transforming growth factor-\u03b21 mediates the beneficial effects of arketamine on demyelination and remyelination in the brains of cuprizone-treated mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"177096"}}